Metraipolis › archive › dc_2aab7728c858
PEGylated thymosin β4 is a thiol-site-specific prodrug treating myocardial infarction in vivo — Europe PMC PMID:42394899
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/42394899
- DOI
- 10.1002/btm2.70144
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-03T15:47:44.030Z
- SHA-256 of the archived text
fb403016bb30f0b1e3f626e6ecb9671e51df3b077373e4ddbefcbc7b4f190633- Stable URL of this page
https://metraipolis.com/documento/dc_2aab7728c858
How to cite
PEGylated thymosin β4 is a thiol-site-specific prodrug treating myocardial infarction in vivo — Europe PMC PMID:42394899 — Europe PMC (en), https://europepmc.org/article/MED/42394899 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_2aab7728c858 (Metraipolis archive dc_2aab7728c858, sha256 fb403016bb30f0b1e3f626e6ecb9671e51df3b077373e4ddbefcbc7b4f190633)
BibTeX
@misc{dc2aab7728c858,
title = {PEGylated thymosin β4 is a thiol-site-specific prodrug treating myocardial infarction in vivo — Europe PMC PMID:42394899},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/42394899},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_2aab7728c858; sha256 fb403016bb30f0b1e3f626e6ecb9671e51df3b077373e4ddbefcbc7b4f190633},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42394899. Agents can read the archived copy with the MCP tool read_document.